Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3
- PMID: 12842902
- DOI: 10.1074/jbc.M303164200
Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3
Abstract
The human combinatorial antibody library Fab 1 (HuCAL-Fab 1) was generated by transferring the heavy and light chain variable regions from the previously constructed single-chain Fv library (Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., and Virnekäs, B. (2000) J. Mol. Biol. 296, 57-86), diversified in both complementarity-determining regions 3 into a novel Fab display vector, yielding 2.1 x 10(10) different antibody fragments. The modularity has been retained in the Fab display and screening plasmids, ensuring rapid conversion into various antibody formats as well as antibody optimization using prebuilt maturation cassettes. HuCAL-Fab 1 was challenged against the human fibroblast growth factor receptor 3, a potential therapeutic antibody target, against which, to the best of our knowledge, no functional antibodies could be generated so far. A unique screening mode was designed utilizing recombinant functional proteins and cell lines differentially expressing fibroblast growth factor receptor isoforms diversified in expression and receptor dependence. Specific Fab fragments with subnanomolar affinities were isolated by selection without any maturation steps as determined by fluorescence flow cytometry. Some of the selected Fab fragments completely inhibit target-mediated cell proliferation, rendering them the first monoclonal antibodies against fibroblast growth factor receptors having significant function blocking activity. This study validates HuCAL-Fab 1 as a valuable source for the generation of target-specific antibodies for therapeutic applications.
Similar articles
-
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.J Mol Biol. 2008 Feb 29;376(4):1182-200. doi: 10.1016/j.jmb.2007.12.018. Epub 2007 Dec 15. J Mol Biol. 2008. PMID: 18191144
-
High-throughput generation and engineering of recombinant human antibodies.J Immunol Methods. 2001 Aug 1;254(1-2):67-84. doi: 10.1016/s0022-1759(01)00398-2. J Immunol Methods. 2001. PMID: 11406154
-
A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes.BMC Biotechnol. 2004 Apr 1;4:6. doi: 10.1186/1472-6750-4-6. BMC Biotechnol. 2004. PMID: 15059288 Free PMC article.
-
Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.Fish Shellfish Immunol. 2023 Jul;138:108808. doi: 10.1016/j.fsi.2023.108808. Epub 2023 May 9. Fish Shellfish Immunol. 2023. PMID: 37169114 Review.
-
Humanization of antibodies.Front Biosci. 2008 Jan 1;13:1619-33. doi: 10.2741/2786. Front Biosci. 2008. PMID: 17981654 Review.
Cited by
-
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.World J Urol. 2006 Nov;24(5):565-78. doi: 10.1007/s00345-006-0119-6. World J Urol. 2006. PMID: 17063322 Review. No abstract available.
-
Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation.Int J Mol Sci. 2019 Apr 15;20(8):1861. doi: 10.3390/ijms20081861. Int J Mol Sci. 2019. PMID: 30991723 Free PMC article. Review.
-
Production of an Efficient Enzymatically Fab Fragment Antivenom against Cobra Snake (Naja naja oxiana) Venom.Arch Razi Inst. 2024 Apr 30;79(2):411-417. doi: 10.32592/ARI.2024.79.2.411. eCollection 2024 Apr. Arch Razi Inst. 2024. PMID: 39463715 Free PMC article.
-
Advances in the Production and Batch Reformatting of Phage Antibody Libraries.Mol Biotechnol. 2019 Nov;61(11):801-815. doi: 10.1007/s12033-019-00207-0. Mol Biotechnol. 2019. PMID: 31468301 Free PMC article. Review.
-
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.J Biol Chem. 2010 Apr 23;285(17):12882-91. doi: 10.1074/jbc.M110.113035. Epub 2010 Feb 19. J Biol Chem. 2010. PMID: 20172854 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources